Principal Financial Group’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.5M Sell
1,390,313
-12,987
-0.9% -$205K 0.01% 1207
2025
Q4
$25.6M Buy
1,403,300
+80,259
+6% +$1.35M 0.01% 748
2025
Q3
$19.4M Sell
1,323,041
-223,394
-14% -$3.83M 0.01% 887
2025
Q2
$28.2M Buy
1,546,435
+258,314
+20% +$5.27M 0.01% 666
2025
Q1
$25.6M Buy
1,288,121
+29,107
+2% +$503K 0.01% 690
2024
Q4
$21.6M Buy
1,259,014
+64,793
+5% +$1.22M 0.01% 814
2024
Q3
$23.9M Buy
1,194,221
+1,059,394
+786% +$16.5M 0.01% 749
2024
Q2
$1.51M Sell
134,827
-1,433
-1% -$12K ﹤0.01% 1807
2024
Q1
$899K Sell
136,260
-22,374
-14% -$122K ﹤0.01% 1880
2023
Q4
$717K Buy
158,634
+23,844
+18% +$88.2K ﹤0.01% 1884
2023
Q3
$483K Buy
134,790
+30,088
+29% +$116K ﹤0.01% 1961
2023
Q2
$386K Buy
104,702
+2,225
+2% +$8.25K ﹤0.01% 2008
2023
Q1
$339K Sell
102,477
-6,673
-6% -$23.1K ﹤0.01% 2059
2022
Q4
$424K Buy
109,150
+29,362
+37% +$90.6K ﹤0.01% 2015
2022
Q3
$194K Sell
79,788
-54,586
-41% -$131K ﹤0.01% 2212
2022
Q2
$266K Buy
134,374
+119,333
+793% +$235K ﹤0.01% 2218
2022
Q1
$28K Sell
15,041
-847
-5% -$1.32K ﹤0.01% 2512
2021
Q4
$22K Sell
15,888
-2,896
-15% -$3.81K ﹤0.01% 2509
2021
Q3
$21K Sell
18,784
-3,043
-14% -$4.26K ﹤0.01% 2569
2021
Q2
$35K Sell
21,827
-338,684
-94% -$596K ﹤0.01% 2591
2021
Q1
$634K Buy
360,511
+24,953
+7% +$57.1K ﹤0.01% 2088
2020
Q4
$655K Buy
335,558
+193,338
+136% +$406K ﹤0.01% 2039
2020
Q3
$340K Buy
142,220
+58,428
+70% +$160K ﹤0.01% 2104
2020
Q2
$246K Buy
+83,792
New +$241K ﹤0.01% 2135

Other funds holding ADMA